EACR26-1631
Replication stress can promote differentiation in acute myeloid leukemia (AML), yet the metabolic determinants of this response remain incompletely defined. We investigated whether disruption of nucleotide metabolism represents a central driver of replication stress–induced differentiation and examined the role of ribonucleotide reductase (RNR) subunits in modulating this process.
AML cell lines (U937, MOLM-13, THP-1) were treated with AICAr, the DHODH inhibitor brequinar, or low-dose cytarabine. Intracellular metabolites were quantified by targeted liquid chromatography coupled to tandem mass spectrometry (LC–MS/MS). Differentiation and cell cycle distribution were assessed by flow cytometry. RNR subunit expression was analyzed by immunoblotting and siRNA-mediated knockdown. Public proteomic datasets from AML cell lines were interrogated to evaluate RRM2/RRM2B abundance patterns.
All differentiation-inducing agents altered nucleotide homeostasis through distinct mechanisms but converged on S-phase arrest. Supplementation with high concentrations of ribo- and deoxyribonucleosides abrogated replication stress and differentiation indicating that a global nucleotide imbalance is required for this phenotype. Replication stress was accompanied by differential regulation of RNR subunits. In p53-mutant U937 cells, RRM2 was strongly induced, and its knockdown led to a dNTP imbalance and enhanced differentiation without reducing viability. In contrast, p53-wild-type MOLM-13 cells predominantly upregulated the p53-inducible isoform RRM2B, and RRM2 depletion impaired both survival and differentiation. Proteomic analysis showed a higher RRM2/RRM2B ratio in p53-mutant than in p53–wild-type AML cell lines.
These findings identify nucleotide imbalance as a key metabolic regulator of AML differentiation and suggest that RNR isoform composition influences cellular responses to replication stress.
We thank Ms. Marijana Andrijasevic for valuable technical assistance. This work has been funded by Croatian Science Foundation under the projects HRZZ IP-2022-10-9146, DOK-2020-01-2873, DOK-2025-02-6776 and DOK-NPOO-2023-10-9321 by the European Union through the ESF Operational Programme Efficient Human Resources (to DV).